Results 211 to 220 of about 38,749 (246)

Use of cystatin C biomarker in patients with possible renal failure

open access: green, 2019
Alexander Benavides Couto   +5 more
openalex   +1 more source

[Cystatin C: yes, but...].

open access: yesNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2007
openaire   +1 more source

N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy: A Nonrandomized Clinical Trial.

open access: yesJAMA Neurol
Snorradottir AO   +16 more
europepmc   +1 more source

Cystatin C and intravenous thrombolysis

European Journal of Neurology, 2021
With great interest, we read the recent original article written by Zihan Chang et al1 , which was published in European Journal of Neurology. In this multicenter retrospective case-control study, the authors found that elevated serum Cystatin C may be associated with unfavorable clinical outcomes after intravenous tissue plasminogen activator therapy,
Meidi Peng, Yupei Chen, Guiling Geng
openaire   +2 more sources

Cystatin C

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2002
Clinical biochemists have long known the analytical and clinical limitations of creatinine and creatinine clearance measurement in the assessment of glomerular filtration rate (GFR). This background is reviewed in the article before assessing the utility of cystatin C, the most promising replacement biochemical marker yet identified.
openaire   +2 more sources

Cystatin C in Cerebrovascular Disorders

Current Neurovascular Research, 2018
Cystatin C (CysC), a cysteine protease inhibitor, has been widely proven to be a highly sensitive biomarker to predict the kidney function. The similarity of the renal and cerebral small vessels has awakened a surge of studies suggesting that CysC plays a key role in various cerebrovascular disorders.
Yaru, Zhang, Li, Sun
openaire   +2 more sources

Home - About - Disclaimer - Privacy